Citations (15)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Jie Cheng, Yueying Zhen, Sharon Miksys, Diren Beyoğlu, Kristopher W. Krausz, Rachel F. Tyndale, Aiming Yu, Jeffrey R. Idle & Frank J. Gonzalez. (2013) Potential role of CYP2D6 in the central nervous system. Xenobiotica 43:11, pages 973-984.
Read now
Read now
Chi Chen, Frank J. Gonzalez & Jeffrey R. Idle. (2007) LC-MS-Based Metabolomics in Drug Metabolism. Drug Metabolism Reviews 39:2-3, pages 581-597.
Read now
Read now
B. Clark, D. A. Smith, C. T. Eason & D. V. Parke. (1982) Metabolism and excretion of a chromone carboxylic acid (FPL 52757) in various animal species. Xenobiotica 12:3, pages 147-153.
Read now
Read now
J. R. Idle & R. L. Smith. (1979) Polymorphisms of Oxidation at Carbon Centers of Drugs and Their Clinical Significance. Drug Metabolism Reviews 9:2, pages 301-317.
Read now
Read now
Articles from other publishers (11)
Brian R. Cooke, S. W. Annie Bligh, Z. Richard Cybulski, Costas Ioannides & Michael Hall. (2012) Debrisoquine Metabolism and CYP2D Expression in Marmoset Liver Microsomes. Drug Metabolism and Disposition 40:1, pages 70-75.
Crossref
Crossref
Hidetaka Kamimura, Naoyuki Nakada, Katsuhiro Suzuki, Ayako Mera, Kinya Souda, Yuichi Murakami, Kohichiro Tanaka, Takafumi Iwatsubo, Akio Kawamura & Takashi Usui. (2010) Assessment of Chimeric Mice with Humanized Liver as a Tool for Predicting Circulating Human Metabolites. Drug Metabolism and Pharmacokinetics 25:3, pages 223-235.
Crossref
Crossref
Yueying Zhen, Ondřej Slanař, Kristopher W. Krausz, Chi Chen, Josef Slavík, Kerry L. McPhail, T. Mark Zabriskie, František Perlík, Frank J. Gonzalez & Jeffrey R. Idle. (2006) 3,4-Dehydrodebrisoquine, a Novel Debrisoquine Metabolite Formed from 4-Hydroxydebrisoquine That Affects the CYP2D6 Metabolic Ratio. Drug Metabolism and Disposition 34:9, pages 1563-1574.
Crossref
Crossref
Javier Corchero, Camille P. Granvil, Taro E. Akiyama, Graham P. Hayhurst, Satish Pimprale, Lionel Feigenbaum, Jeffrey R. Idle & Frank J. Gonzalez. (2001)
The
CYP2D6
Humanized Mouse: Effect of the Human
CYP2D6
Transgene and
HNF4α
on the Disposition of Debrisoquine in the Mouse
. Molecular Pharmacology 60:6, pages 1260-1267.
Crossref
Crossref
C. Goubier, I. Girard & S. Ferry. (1991) High-performance liquid chromatographic assay of debrisoquine and its 4-hydroxy metabolite in human urine. Chromatographia 32:11-12, pages 523-526.
Crossref
Crossref
M Eichelbaum, L Bertilsson, A Kupfer, E Steiner & CO Meese. (2012) Enantioselectivity of 4‐hydroxylation in extensive and poor metabolizers of debrisoquine.. British Journal of Clinical Pharmacology 25:4, pages 505-508.
Crossref
Crossref
BK Park. (2012) Assessment of the drug metabolism capacity of the liver.. British Journal of Clinical Pharmacology 14:5, pages 631-651.
Crossref
Crossref
S. Murray & K. A. Waddell. (1982) The electron capture negative ion chemical ionization mass spectra of 2-(4′,6′-bistrifluoromethyl-2′-pyrimidinyl)-tetrahydroisoquinoline and 4-substituted analogues. Biological Mass Spectrometry 9:11, pages 466-472.
Crossref
Crossref
GC Kahn, AR Boobis, S Murray, MJ Brodie & DS Davies. (2012) Assay and characterisation of debrisoquine 4‐hydroxylase activity of microsomal fractions of human liver.. British Journal of Clinical Pharmacology 13:5, pages 637-645.
Crossref
Crossref
A. J. Smith & G. T. Tucker. 1981. Adrenergic Activators and Inhibitors. Adrenergic Activators and Inhibitors
417
504
.
JR Idle, A Mahgoub, MM Angelo, LG Dring, R Lancaster & RL Smith. (2012) The metabolism of [14C]‐debrisoquine in man.. British Journal of Clinical Pharmacology 7:3, pages 257-266.
Crossref
Crossref